Our team attended Asia Pharma Expo 2026 in Dhaka, Bangladesh. We presented our high-quality API products, and had in-depth exchanges with local pharmaceutical enterprises. This exhibition built close business connections in South Asia. We will continue to deliver stable quality and thoughtful services for global partners.
Our Presence at Bangladesh Asia Pharma Expo 2026 Read More »
As oligonucleotide therapies enter a critical growth phase—expanding from rare diseases to large indications like cardiovascular and metabolic disorders—the regulatory landscape is evolving rapidly to balance innovation, patient safety, and supply chain resilience. In 2026, key regulatory bodies worldwide are implementing landmark reforms and targeted guidelines that directly impact oligonucleotide active pharmaceutical ingredient (API) development,
2026 Global Regulatory Trends Shaping Oligonucleotide API Development and Compliance Read More »
As the clock strikes the start of 2026 and we bid farewell to the old year, we extend our warmest New Year greetings to all colleagues in the global pharmaceutical industry, friends from domestic and overseas pharmaceutical enterprises, dedicated researchers, medical professionals, and every individual who contributes to the cause of human health!
2026 New Year Message: Forging Ahead Together to Build a Healthier Future Read More »
The global key Active Pharmaceutical Ingredients (APIs) market has seen notable price volatility in the final quarter of 2025, driven by evolving supply chain dynamics, regulatory adjustments, and fluctuating demand across therapeutic segments. This trend has brought both challenges and strategic opportunities for pharmaceutical manufacturers and supply chain partners worldwide. Key drivers behind the price
Recent Shifts in Key API Prices: Drivers and Market Implications Read More »
The synthesis of Active Pharmaceutical Ingredients (APIs) is undergoing a significant transformation. Moving beyond traditional batch processes, the industry is embracing advanced technologies that promise enhanced efficiency, superior quality control, and a reduced environmental footprint. Here are the key innovative trends shaping the future of API manufacturing. 1. Continuous Flow Chemistry: The New ParadigmContinuous flow
Emerging Frontiers in API Synthesis: Innovation Driving Efficiency and Sustainability Read More »
The global Active Pharmaceutical Ingredients (API) market continues its robust expansion, with recent 2024 analyses and 2025 projections estimating the market size at approximately USD 220-225 billion. Growth is steady, driven by several interconnected factors. Key Growth Drivers:The demand for generic drugs, especially for managing chronic diseases, remains a foundational pillar. More dynamically, the biologics segment (including monoclonal
Active Pharmaceutical Ingredients Market: Sustained Growth and Strategic Shifts in 2025 Read More »
